These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9606445)

  • 1. Risedronate released for Paget's disease.
    Am J Health Syst Pharm; 1998 May; 55(10):984. PubMed ID: 9606445
    [No Abstract]   [Full Text] [Related]  

  • 2. Risedronate: a new oral bisphosphonate.
    Umland EM; Boyce EG
    Clin Ther; 2001 Sep; 23(9):1409-21. PubMed ID: 11589256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risedronate for Paget's disease of bone.
    Med Lett Drugs Ther; 1998 Aug; 40(1034):87-8. PubMed ID: 9731243
    [No Abstract]   [Full Text] [Related]  

  • 4. Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study.
    Brown JP; Hosking DJ; Ste-Marie L; Johnston CC; Reginster J; Ryan WG; Johnson TD; Bekker PJ
    Calcif Tissue Int; 1999 Feb; 64(2):93-9. PubMed ID: 9914313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.
    Miller PD; Brown JP; Siris ES; Hoseyni MS; Axelrod DW; Bekker PJ
    Am J Med; 1999 May; 106(5):513-20. PubMed ID: 10335722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of risedronate in Paget's disease.
    Miller PD
    Bone; 1999 May; 24(5 Suppl):91S-92S. PubMed ID: 10321937
    [No Abstract]   [Full Text] [Related]  

  • 7. Paget's disease of bone: reduction of disease activity with oral risedronate.
    Hosking DJ; Eusebio RA; Chines AA
    Bone; 1998 Jan; 22(1):51-5. PubMed ID: 9437513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risedronate, a new diphosphonate in osteoporosis and Paget's disease].
    Bannwarth B
    Presse Med; 2002 Mar; 31(8):340-2. PubMed ID: 11913075
    [No Abstract]   [Full Text] [Related]  

  • 9. Risedronate in Paget's disease: preliminary results of a multicenter study.
    Brown JP; Kylstra JW; Bekker PJ; Axelrod DW; Siris ES; Altman RD; Singer FR
    Semin Arthritis Rheum; 1994 Feb; 23(4):272. PubMed ID: 8009253
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in bone mineral density in patients with Paget's disease treated with risedronate.
    Patel S; Pearson D; Bhallah A; Maslanka W; White DA; Hosking DJ
    Ann Rheum Dis; 1997 Jul; 56(7):405-9. PubMed ID: 9486001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risedronate: clinical usage.
    Chapurlat RD; Delmas PD
    Int J Clin Pract; 2001 May; 55(4):275-8. PubMed ID: 11406915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risedronate in the treatment of Paget's disease of bone: an open label, multicenter study.
    Siris ES; Chines AA; Altman RD; Brown JP; Johnston CC; Lang R; McClung MR; Mallette LE; Miller PD; Ryan WG; Singer FR; Tucci JR; Eusebio RA; Bekker PJ
    J Bone Miner Res; 1998 Jun; 13(6):1032-8. PubMed ID: 9626635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paget's disease and bisphosphonates.
    Rendina D; De Filippo G; Mossetti G
    N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16365936
    [No Abstract]   [Full Text] [Related]  

  • 14. Risedronate, a highly effective oral agent in the treatment of patients with severe Paget's disease.
    Singer FR; Clemens TL; Eusebio RA; Bekker PJ
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1906-10. PubMed ID: 9626117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paget's disease and its therapeutic management].
    Orcel P; Rousière M
    Presse Med; 2005 Apr; 34(8):612-6. PubMed ID: 15962504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of pagetic bone lesions with risedronate treatment: a radiologic study.
    Brown JP; Chines AA; Myers WR; Eusebio RA; Ritter-Hrncirik C; Hayes CW
    Bone; 2000 Mar; 26(3):263-7. PubMed ID: 10709999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
    Hosking DJ
    Bone; 1999 May; 24(5 Suppl):69S-71S. PubMed ID: 10321933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
    [No Abstract]   [Full Text] [Related]  

  • 19. Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.
    Dunn CJ; Goa KL
    Drugs; 2001; 61(5):685-712. PubMed ID: 11368289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effects of risedronate on Paget's disease of bone].
    Takata S
    Clin Calcium; 2006 Sep; 16(9):1508-12. PubMed ID: 16951476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.